June 15, 2001
MEDIA CONTACT: Vanessa Wasta
Richard Ambinder, M.D., Ph.D., director of the Division of Hematologic Malignancies at the Johns Hopkins Oncology Center, has been named the first James B. Murphy Professor of Oncology. Ambinder is an internationally recognized expert on the Epstein-Barr virus and its relationship to cancer, namely posttransplant lymphoma, Burkitt’s lymphoma, AIDS-related lymphoma, Hodgkin’s disease and nasopharyngeal cancer. Since he joined the faculty in 1984, Ambinder’s research has focused on the application of molecular biology and immunology to the diagnosis and treatment of virus-associated malignancies. In addition, he has played a key role in the development of new therapeutic strategies that target virus-infected cells.